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Objective: To determine factors associated with repeat revascularization among adults aged 25 years and above
within 5 years of first Percutaneous Coronary Intervention (PCI) at a tertiary care hospital.
Methods: A matched case-control study was conducted through a hospital records review. A total of 90 cases with
repeat revascularization and 180 controls without repeat revascularization were included. Data was analyzed
using Multiple Conditional Logistic Regression.
Results: The mean age was similar in cases and controls (60.05 ± 10.01 vs 62.20 ± 10.43 years) and sex (male:
77.8% vs. 76.1%). History of being an ever-smoker (40% vs. 25%), overweight (36.3% vs. 30.6%), and poor
glycemic control (23.3% vs. 12.2%) were more among the cases than controls. However, obesity (53.7% vs.
44.3%) and pre-diabetes (16.1% vs. 7.8%) were more in controls compared to cases.
Upon matching on the time of index PCI, the adjusted odds of ever smokers among patients with repeat
revascularization was 2.47 times the odds of ever smokers among patients who did not undergo revasculariza
tion. Increasing stent diameter by 1 mm was found to reduce the risk of repeat revascularization by 51%.
Conclusions: Smoking cessation and appropriate selection of stent diameter in patients undergoing revasculari
zation can reduce the risk of repeat revascularization in the future.

1. Introduction
Percutaneous Coronary Intervention (PCI) is a common procedure to
revascularize coronary arteries. It is a nonsurgical invasive procedure
that restores blood flow to the heart (revascularization). It opens arteries
that are constricted by atherosclerotic plaque. Over time, advanced
procedural techniques and adjunct pharmacological therapies have
resulted in better outcomes post PCI, repeat revascularization remains a
significant cause for readmission after initial revascularization. Repeat

revascularization is defined as repeating the intervention which could be
PCI or Coronary Artery Bypass Grafting (CABG) for restoring blood flow
to the coronary arteries once a patient has been discharged after first or
index PCI [1]. The requirement for repeat revascularization can differ
depending on the risk and individual characteristics of a patient.
Repeat revascularization is often studied as an outcome or endpoint
in Major Adverse Cardiac Events (MACE) after undergoing PCI or in
comparative studies such as PCI vs. CABG [2]. Globally, few trials have
been conducted which reported its incidence rate between 9 and 12%

Abbreviations: AHA, American Heart Association; BMS, Bare Metal Stent; BMI, Body Mass Index; CI, Confidence Interval; CABG, Coronary Artery Bypass Grafting;
CAD, Coronary Artery Disease; DBP, Diastolic Blood Pressure; DES, Drug Eluting Stent; HIMS, Hospital Information Management System; ISR, In-stent restenosis;
IQR, Inter-quartiles range; JCI, Joint Commission International; MACE, Major Adverse Cardiac Events; MOR, Matched Odds Ratio; PCI, Percutaneous Coronary
Intervention; SBP, Systolic Blood Pressure.
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undergoing index PCI (from 2011 to 2017). However, patients were
excluded from being a case if suffering from any hypercoagulable dis
order, revascularization procedure was performed outside the study
setting, had staged PCI within 3 weeks or planned PCI within 6 months
of Index PCI. The staged procedure was defined as the planned PCI once
a patient has been discharged after the index procedure [20].

annually [2–5]. A similar incidence rate was observed in the EVENT
registry conducted in 55 centers of the United States, which reported a
12% incidence of repeat revascularization within a year. The 9% of
repeat procedures were unplanned [5]. The studies concerning the risk
of repeat revascularization, however, are limited indeed and risk factors
identified are usually restricted to specific patient groups such as pa
tients suffering from chronic kidney disease, diabetes, or other groups of
diseases [6–10].
Coronary Artery Disease (CAD) affects South Asian descent to a
greater extent due to markedly worse risk factor profile and more
extensive disease [11]. It presents earlier in age and is associated with
disease progression after index PCI and contributes to the high cardio
vascular death rates in the region [12]. Studies conducted have reported
the occurrence of hypertension, diabetes, hyperlipidemia, and a history
of CAD to present even earliest than 40 years of age [13–15]. Also,
recurrent myocardial ischemia was common within 12 months of index
PCI [16]. A study conducted at a tertiary care hospital in Karachi
identified that 34 out of 610 patients undergoing CABG had the previous
stenting. Re-intervention was required due to aggressive disease pro
gression and restenosis [17].
This study aimed to identify risk factors of repeat revascularization
after undergoing index PCI including patient characteristics, comor
bidities, smoking behavior, procedure related, and other such factors
among adults aged 25 years and older visiting tertiary care hospital.

2.3.2. Eligibility criteria for controls
Inclusion criteria for controls included patients aged 25 years and
older and who had undergone PCI once from the year 2011–2017.
However, patients were excluded from the control group if they had any
hypercoagulable disorder.
The non-probability consecutive sampling strategy was used to
identify patients from the provided list of medical records. Patients were
recruited in the study if they fulfilled the eligibility criteria for being a
case or control and were selected until the required sample was ach
ieved. Previous exposures were subsequently explored for each patient.
For controls, the tool assessed the exposure status after index angio
plasty while for cases, the tool assessed the exposure status postangioplasty and before undergoing repeat revascularization.
2.3.3. Matching variable
The time of index PCI could be a potential confounder in this study.
The reason behind undergoing repeat procedures within a year of index
PCI could be different than undergoing the procedure after a few years of
index PCI. This was handled by matching the time of undergoing initial
PCI in both study groups that is the year of undergoing index PCI. For
instance, a case that had undergone index PCI in the year 2012 was
matched with two controls who had index PCI in 2012 i-e 1:2 case to
control ratio.

2. Methods
2.1. Study design
Matched case-control study design was employed to determine the
association between repeat revascularization and its determinants in
patients within 5 years of undergoing index PCI. The case was defined as
a patient who had undergone repeat revascularization within 5 years of
undergoing index PCI. Control was defined as a patient who had not
undergone repeat revascularization within 5 years of undergoing index
PCI.

2.4. Outcome and study variables
The outcome of our study was the Repeat revascularization status.
There are different types of repeat revascularization according to the site
and lesion to which intervention has been provided. Any type of repeat
revascularization was considered and enrolled as a case in this study [5].
Covariates included in the study were divided into patient charac
teristics (gender, age, health coverage, Body Mass Index (BMI), smoking
status), comorbidity status (Hypertension, Diabetes Mellitus, Hyper
lipidaemia, valvular disease), clinical characteristics (Creatinine level,
Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), HbA1c,
Cholesterol level, other technical factors related to the index PCI) and
medication status (Beta-blocker, ACE Inhibitor, Statin).
For BMI, well-established biological cutoffs were available. The
Asian cutoff ranges a BMI lower than 18.5 kg/m2 suggests the person is
underweight, a BMI from 18.5 up to 23 kg/m2 indicates the normal
weight, from 23 up to 27.5 kg/m2 indicates the person is overweight,
and from 27.5 kg/m2 upwards suggests the person is obese [21,22].
Moreover, the AHA defined categories for left ventricular ejection
fraction [23] and the biological cutoff was used for average HbA1c.

2.2. Study setting
The retrospective study was carried out with the approval of the
Ethical Review Committee of the tertiary care hospital where the study
was carried out. A waiver of informed consent was granted as this was a
retrospective study and all patients were discharged from the hospital.
No personal identifiers were included in data collection, and records
were anonymized to the statistician. To reduce the variability due to
technique and its related factors, this site was selected as it follows the
international guidelines and protocol including Joint Commission In
ternational (JCI) accreditation and the American Heart Association
(AHA) which provide evidence-based Clinical Practice Guidelines [18].
These practices are standardized throughout the hospital that is ensured
by internal and external quality audits. This article has been submitted
in line with the STROCSS guidelines [19]. and has been registered with
the Research Registry with a (UID: NCT05189249). https://clinicaltr
ials.gov/ct2/show/NCT05189249.

2.5. Statistical methods
All the analysis was carried out using STATA software (version 13.0).
For normally distributed quantitative variables, mean and standard
deviation are reported whereas, median and inter-quartiles range (IQR)
are stated for variables deviating from normality. Frequencies and
proportions are reported for qualitative variables.
Variables were regressed with the Repeat revascularization status
using simple Conditional Logistic Regression. Univariate analysis was
conducted by computing Crude Matched Odds Ratio (MOR) and their
95% Confidence Interval (CI) to compare cases and controls for different
factors. The cutoff of p-value <0.25 was considered as significant at the
univariate level to be eligible for multivariable analysis. Multi
collinearity was assessed between covariates at the cutoff equal to or

2.3. Participants
A minimum of 120 cases with matched 240 controls were required in
1:2 case to control ratio. This sample size was essential to achieve the
power of 80% for an anticipated matched odds ratio of 2 with the hy
pothesized correlation of 0.2 using a two-sided hypothesis test with a
significance level of 0.05.
2.3.1. Eligibility criteria for cases
Inclusion criteria for cases included patients aged 25 years and older
and who had undergone repeat revascularization within 5 years of
2
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more than 0.8.
All independent variables were regressed with the outcome through
Multiple Conditional Logistic Regression by using the stepwise method.
With each extension of the model, the likelihood ratio test was used to
decide the inclusion of further variables which are considerably
improving the fit of the model. Matched Odds Ratios and 95% Confi
dence Interval (CI) were reported for statistically significant variables in
the final model. A p-value of less than or equal to 0.05 was considered
significant.

Table 2
Clinical characteristics of study participants according to their repeat revascu
larization status.
Variables

3.1. Descriptive data
A total of 1055 patient record files were reviewed, from which 90
cases and 180 matched controls were identified meeting the eligibility
criteria, and were included in the study. The mean age of the partici
pants (60.05 ± 10.01 vs 62.20 ± 10.43 years) and the proportion of
males (77.8% vs. 76.1%) was found similar in cases and controls
(Table 1). History of being ever smokers (40% vs. 25%), and overweight
(36.3% vs. 30.6%) was more common among cases than controls.
However, non-smokers (66.7% vs. 44.4%), self-payers of healthcare
(93.3% vs. 78.9%), and obesity (53.7% vs. 44.3%) were more common
in controls compared to cases.
Comorbidity status was approximately similar in both groups.
Among clinical characteristics, around half of the participants in cases
and controls had normal HbA1c or good glycemic control (Table 2). On
the other hand, more cases were found with poor glycemic control with
HbA1c greater than 8.5% than in controls (23.3% vs. 12.2%). In
contrast, controls were found to have a higher number of patients with
pre-diabetes (16.1% vs. 7.8%) and cholesterol level (136.87 ± 31.58 vs.
130.90 ± 30.17 mg/dl) as compared to cases.
Medication status post-index PCI was also found similar among cases
and controls. It included glycoprotein IIb/IIIa Inhibitors (51.1%
vs.54.4%), ACE inhibitor (47.8% vs.53.3%), angiotensin II receptor
blocker (ARBs) (14.4% vs.12.2%), beta-blocker (88.9% vs 93.9%), statin
(95.6% vs 98.3%) and anticoagulants (8.9% vs. 5%) respectively. All of
Table 1
Characteristics of the study participants according to their repeat revasculari
zation status.

Patient characteristics
Male gender
Age (Years)a
Health coverage status (selfpayers)
Weight (in kg)a
Body Mass Index
Under or Normal
Over weight
Obese
Smoking status
Non-smoker
Ever smoker
Not reported
Smokeless Tobacco Status
Never user
Ever user
Not reported
Alcohol user
Never user
Ever user
Not reported
a

a
b

Repeat Revascularization Status
Cases (n =
90)

Controls (n =
180)

n (%)

n (%)

70 (77.8)
60.05 (10.01)
71 (78.9)

137 (76.1)
62.20 (10.43)
168 (93.3)

0.76
0.01
0.01

70.66 (13.26)

73.91 (14.35)

0.09

17 (19.3)
32 (36.3)
39 (44.3)

25 (15.6)
49 (30.6)
86 (53.7)

0.45

40 (44.4)
36 (40.0)
14 (15.6)

120 (66.7)
45 (25.0)
15 (8.3)

0.01

69 (76.7)
7 (7.8)
14 (15.6)

147 (81.7)
18 (10.0)
15 (8.3)

0.19

71 (78.9)
5 (5.6)
14 (15.6)

160 (88.9)
5 (2.8)
15 (8.3)

0.09

Cases (n = 90)

Controls (n = 180)

n (%)

n (%)

Comorbidity status
Valvular disease
No disease
36 (32.2)
Mild
26 (28.9)
Moderate
11 (12.2)
Severe
0 (0.0)
Not Available
15 (16.7)
Clinical Characteristics
a
SBP (in mmHg)
123.50 (18.67)
69.73 (8.15)
DBP (in mmHg)a
HbA1c
Normal <5.7%
45 (50.0)
Pre-diabetic 5.7–6.5%
7 (7.8)
6.5–7.5%
13 (14.4)
7.5–8.5%
4 (4.4)
>8.5%
21 (23.3)
b
LDL (in mg/dl)
68.25 (42–123.66)
b
HDL (in mg/dl)
35 (24–52)
Triglyceride (in mg/dl)b
135 (75–252)
Number of Diseased vessels
I
41 (45.6)
II
35 (38.9)
III
14 (15.6)
Number of stents
Single
58 (64.4)
Double
24 (26.7)
Multi
8 (8.9)
Type of stents
Drug Eluting Stent (DES)
69 (76.7)
Bare Metal Stent (BMS)
16 (17.8)
Both (DES & BMS)
5 (5.6)
b
Stent Diameter (in mm)
2.82 (0.37)
Stent Length (in mm)b
22 (15–38)
Ejection Fraction (Valvular Heart Disease)
Normal
6 (17.8)
Mild
35 (38.9)
Moderate
14 (15.6)
Severe
19 (21.1)
Echo not recommended
16 (17.8)

3. Results

Variable

Repeat Revascularization Status
P-value

61 (33.9)
50 (27.8)
23 (12.8)
5 (2.8)
41 (22.8)

0.13

128.62 (17.81)
69.73 (8.15)

0.02
0.33

99 (55.0)
29 (16.1)
19 (10.6)
11 (6.1)
22 (12.2)
71.25 (36–138.4)
38 (26–59)
118 (72.33–244.4)

0.06

100 (55.6)
56 (31.1)
24 (13.3)

0.29

107 (59.4)
48 (26.7)
25 (13.9)

0.43

129 (71.7)
44 (24.4)
7 (3.9)
2.91 (0.42)
21.5 (12–40)

0.41

8 (4.4)
59 (32.8)
36 (20.0)
32 (17.8)
45 (25.0)

0.45

0.92
0.35
0.06

0.03
0.11

Mean (Standard Deviation).
Median (Inter-quartiles range).

the patients were prescribed dual antiplatelet at the time of discharge.

Pvalue

3.2. Main results
To perform conditional logistic regression, univariate analysis was
performed by regressing independent variables with the outcome. Age
was found to be significant with the crude MOR 0.98 (95% CI l
0.95–1.01). Other significant variables include health coverage, weight,
smoking status, smokeless tobacco, alcohol user, valvular disease, SBP,
HbA1c, triglyceride, number of diseased vessels, stent diameter, betablocker, statin and anti-coagulant. Statistically significant variables at
this stage were selected for the multivariable model and those variables
were entered first which had the least p-value.
In the final multivariable model, smoking status, health coverage
status and stent diameter were found statistically significant by keeping
all other variables constant (Table 3). Upon matching on the time of
index PCI, the adjusted odds of current smoker among repeat revascu
larized patients was 2.47 times than the odds of current smoker in a
patient who was revascularized once.
4. Discussion
Repeat revascularization is one of the areas in which very few studies

Mean (Standard Deviation).
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important to inquire about smoking status at each clinical encounter to
counsel patients for quitting their habit [25]. Although these patients
remain at risk of relapse, additional efforts are required to develop more
effective and well-tolerated strategies to assist cessation and sustain
abstinence from it. Health coverage and its association are less studied in
repeat revascularization studies. Moreover, there are only limited data
available to examine the effect of stent diameter in our routine clinical
practice. These require further investigation to study its role in the
occurrence of repeat revascularization in our population.
It also suggested that the future large-scale multicenter prospective
studies should be conducted to evaluate the role of exercise, medication
adherence, lifestyle modification and the role of biochemical milieu
with repeat revascularization in our setting which is likely to give
further major contributions.

Table 3
Multiple Conditional Logistic analysis showing factors associated with repeat
revascularization.
Variable

Category

Adjusted
Matched Odds
Ratio

Smoking
Status

Non-smoker
Ever smoker
Not
reported
Self-pay
Third party
payer

Health
coverage
status
Stent diameter

95% Confidence
Interval

pvalue

1
2.47
2.43

1.34–4.55
1.01–5.84

0.01
0.05

1
3.27

1.51–7.08

0.01

0.49

0.25–0.99

0.05

have been conducted in South Asia. This study is one of the initial studies
which aimed to identify the key determinants that are associated with
repeat revascularization in CAD patients after undergoing initial PCI
from a large tertiary care hospital. Our study reports smoking status,
health coverage status and stent diameter as the factors affecting the
outcome of index PCI in our study population and were related to the
repeat revascularization.
Similar to the study findings, other studies have reported ever
smokers undergoing PCI have an increased risk of repeat revasculari
zation than those who have either stopped smoking or have never
smoked [24]. Smoking is a modifiable risk factor and approximately
10–30% of the patients with known CAD continue their smoking habit;
however, not all current smokers remain smokers after a coronary event
or an intervention. Patients have benefited from smoking cessation
counseling offered post-procedure and have reduced the proportion of
current smokers to half [24]. Furthermore, a study conducted in the
United States reported that smoking cessation counseling for current
smokers at the time of index PCI reduced the first thirty-days mortality
by 23% and over seventeen years by 8%. This resulted in an average gain
of 0.13–0.58 years of life which is the largest ever reported for old age
smokers [25]. Hence, smoking cessation counseling after index PCI
should be incorporated as a mandatory component in discharge teaching
as it can help to sensitize patients towards the issue and assist them in
reducing or quitting smoking. This will decrease the chance of future
repeat revascularization.
Health coverage is an important aspect of the healthcare system. Our
study showed that the patients with health coverage presented more
frequently for repeat revascularization than those who were self-payer;
hence, were associated with a higher odds ratio. Insured patients are less
worried about their healthcare cost coverage, they might have regular
follow-ups and adherence to the physician’s order [26]. In contrast,
financial concerns might discourage people from coming to a cardiac
facility. This relationship has not been studied extensively in our settings
which prompts for further search.
Also, stent diameter has emerged as a significant factor in this study.
Inappropriate selection of stent diameter could be a great threat to
repeat revascularization. Increasing stent diameter by 1 mm was found
to reduce the risk of repeat revascularization by 51%. A similar finding
was reported in the BASKET-PROVE trial that was conducted in four
countries. It stated that the risk of In-stent restenosis (ISR) decreased by
76% with an increase in stent diameter by 1 mm [27]. Besides, another
study conducted on a large cohort of ethnically diverse patients under
going PCI with DES reported smaller stent diameter to be associated
with increased MACE, leading to higher rates of repeat revascularization
[28].
Since, CAD accounts for a significant burden of morbidity, mortality
and health expenditures in low-middle income countries; public health
personal should focus on developing relevant risk assessment tools, costeffective prevention and therapeutic strategies [29]. As smoking is
associated with poor outcomes post-angioplasty, this information is
significant for patients, physicians and the general population. It is

4.1. Strengths and limitations
In our population, research pertinent to repeat revascularization has
been very limited. This study is an initial effort to explore the factors that
may be related to the outcome of repeat revascularization following an
initial PCI and hence would set the stage for future studies. In addition,
the study was conducted in a JCI accredited tertiary care hospital and
the availability of a well-maintained systematic record system at the
hospital helped us to extract study data and clinical characteristics of
patients more comprehensively.
The study has certain limitations. As the study was conducted at a
single center, the findings of the study are limited in generalizability to
the CAD patients in the community. Being a case-control study, it was at
potential risk of selection bias. As hospital-based cases represent a more
severe form of the disease, controls were also identified from the same
list from which cases were selected in an attempt to minimize this bias.
Furthermore, potential misclassification bias may exist because cases
might have opted for repeat revascularization outside of the study site.
The lack of an integrated healthcare system in the city has made us rely
entirely on the Hospital Information Management System (HIMS) data.
However, information was thoroughly reviewed that was available in
the patient’s file.
It is also a possibility that a reporting bias may have occurred to
certain variables that are socially less desirable and are associated with
stigmas, such as alcohol consumption and smoking. This could have
diluted the difference among cases and controls, and the impact re
ported might be an underestimation of association with repeat revas
cularization. Nevertheless, the study suggests an association between
smoking and repeat revascularization which may be a more severe
problem than estimated in the study [25].
5. Conclusion
Risk factors play a vital role in the disease progression after index PCI
and in the occurrence of repeat revascularization. Smoking and smaller
stent diameter were noted to be associated with higher rates of repeat
revascularization in our study population. These findings highlight the
significance of targeted strategies aiming at patients undergoing index
coronary intervention. Appropriate selection of stent diameter is crucial
in reducing the risk of repeat revascularization. Incorporation of
smoking cessation counseling in discharge teaching and inquiry of
smoking status at each clinical encounter is important to provide more
effective and well-tolerated strategies to assist cessation and sustain
abstinence. Future prospective multicenter studies are required to assess
role of other related risk factors to help improve the outcomes of patients
after PCI.
Ethical approval
The ethics committee of the Aga Khan University approved this study
(5004-CHS-ERC-17).
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